Sara Khaksar

1.6k total citations
22 papers, 230 citations indexed

About

Sara Khaksar is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Sara Khaksar has authored 22 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 5 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in Sara Khaksar's work include Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (15 papers) and Urologic and reproductive health conditions (5 papers). Sara Khaksar is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (15 papers) and Urologic and reproductive health conditions (5 papers). Sara Khaksar collaborates with scholars based in United Kingdom, Singapore and Germany. Sara Khaksar's co-authors include Stephen Langley, Robert Laing, Roger Dale, Bleddyn Jones, David Lovell, Julian Money‐Kyrle, Santiago Uribe‐Lewis, Prasanna Sooriakumaran, Jenny Nobes and M. Hawkins and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and BMC Cancer.

In The Last Decade

Sara Khaksar

19 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Khaksar United Kingdom 9 189 67 39 33 28 22 230
Lennart Åström Sweden 9 247 1.3× 119 1.8× 20 0.5× 34 1.0× 15 0.5× 20 294
Elise De Bleser Belgium 10 179 0.9× 29 0.4× 45 1.2× 63 1.9× 29 1.0× 17 234
P. Graff-Cailleaud France 6 186 1.0× 62 0.9× 60 1.5× 20 0.6× 14 0.5× 14 224
O. Gilliot France 5 180 1.0× 57 0.9× 48 1.2× 46 1.4× 6 0.2× 11 247
Chris Brawley United Kingdom 5 265 1.4× 52 0.8× 36 0.9× 71 2.2× 7 0.3× 11 301
John Dombrowski United States 6 249 1.3× 191 2.9× 46 1.2× 32 1.0× 12 0.4× 11 302
Mahendra Pal India 8 257 1.4× 130 1.9× 136 3.5× 41 1.2× 48 1.7× 41 373
Marketa Skala Australia 13 278 1.5× 158 2.4× 62 1.6× 96 2.9× 27 1.0× 23 392
Igor Nunes‐Silva Brazil 9 257 1.4× 15 0.2× 49 1.3× 37 1.1× 32 1.1× 28 291
James Benton United States 7 360 1.9× 163 2.4× 111 2.8× 17 0.5× 20 0.7× 12 454

Countries citing papers authored by Sara Khaksar

Since Specialization
Citations

This map shows the geographic impact of Sara Khaksar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Khaksar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Khaksar more than expected).

Fields of papers citing papers by Sara Khaksar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Khaksar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Khaksar. The network helps show where Sara Khaksar may publish in the future.

Co-authorship network of co-authors of Sara Khaksar

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Khaksar. A scholar is included among the top collaborators of Sara Khaksar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Khaksar. Sara Khaksar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langley, Stephen, Santiago Uribe‐Lewis, Christos Mikropoulos, et al.. (2022). Is hemi-gland focal LDR brachytherapy as effective as whole-gland treatment for unilateral prostate cancer?. Brachytherapy. 21(6). 870–876. 4 indexed citations
2.
Langley, Stephen, Christopher Eden, Matthew Perry, et al.. (2021). Robot‐assisted salvage seminal vesicle excision for isolated recurrence after low‐dose‐rate prostate brachytherapy. British Journal of Urology. 129(6). 731–736. 4 indexed citations
3.
Uribe‐Lewis, Santiago, Christos Mikropoulos, Sophie Otter, et al.. (2021). Long‐term survival after low‐dose‐rate brachytherapy for prostate cancer: the Royal Surrey experience. British Journal of Urology. 129(6). 723–730. 2 indexed citations
4.
Langley, Stephen, et al.. (2019). Hemi‐ablative low‐dose‐rate prostate brachytherapy for unilateral localised prostate cancer. British Journal of Urology. 125(3). 383–390. 13 indexed citations
6.
Laing, Robert, et al.. (2018). Low‐dose‐rate brachytherapy for the treatment of localised prostate cancer in men with a high risk of disease relapse. British Journal of Urology. 122(4). 610–617. 6 indexed citations
8.
Langley, Stephen, et al.. (2017). Long‐term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low‐dose‐rate brachytherapy for localised prostate cancer. British Journal of Urology. 121(1). 38–45. 22 indexed citations
9.
Mir, Rashid, et al.. (2014). What Factors Contribute to Late Rectal Toxicity after Prostate Radiotherapy. Clinical Oncology. 26(2). e6–e6.
10.
Nobes, Jenny, et al.. (2008). Novel prostate brachytherapy technique: Improved dosimetric and clinical outcome. Radiotherapy and Oncology. 88(1). 121–126. 13 indexed citations
11.
Nobes, Jenny, Ian Wells, Sara Khaksar, et al.. (2008). Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience. Prostate Cancer and Prostatic Diseases. 12(1). 61–66. 12 indexed citations
12.
Khaksar, Sara, et al.. (2008). Bladder neck resection prior to I125 LDR brachytherapy improves post-implant urinary toxicity. A matched-pair analysis. Brachytherapy. 7(2). 117–117. 1 indexed citations
13.
Nobes, Jenny, et al.. (2007). 814 THE IMPORTANCE OF PROSTATE BRACHYTHERAPY IMPLANT TECHNIQUE ON PENILE BULB DOSIMETRY. European Urology Supplements. 6(2). 226–226.
14.
Khaksar, Sara, Robert Laing, Alastair Henderson, et al.. (2006). Biochemical (prostate‐specific antigen) relapse‐free survival and toxicity after 125 I low‐dose‐rate prostate brachytherapy. British Journal of Urology. 98(6). 1210–1215. 15 indexed citations
15.
Khaksar, Sara, Stephen Langley, David Lovell, & Robert Laing. (2006). Interstitial Low Dose Rate Brachytherapy for Prostate Cancer — A Focus on Intermediate- and High-risk Disease. Clinical Oncology. 18(7). 513–518. 18 indexed citations
16.
Sooriakumaran, Prasanna, Sara Khaksar, & Jyoti Shah. (2006). Management of prostate cancer. Part 2: localized and locally advanced disease. Expert Review of Anticancer Therapy. 6(4). 595–603. 3 indexed citations
17.
Ringash, Jolie, Sara Khaksar, Amit M. Oza, et al.. (2005). Post-operative radiochemotherapy for gastric cancer: adoption and adaptation. Clinical Oncology. 17(2). 91–95. 21 indexed citations
18.
Khaksar, Sara, Robert Laing, & Stephen Langley. (2005). Fertility after prostate brachytherapy. British Journal of Urology. 96(6). 915–915. 8 indexed citations
19.
Sooriakumaran, Prasanna, et al.. (2005). 168Can Europe reproduce the brachytherapy results of the USA?. European Urology Supplements. 4(3). 44–44.
20.
Jones, Bleddyn, et al.. (2000). Biological equivalent dose assessment of the consequences of hypofractionated radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 47(5). 1379–1384. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026